Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 9INDUSTRY 3NIH 2NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Recurrent Squamous Cell Lung Carcinoma 2Prostatic Neoplasms 2Colorectal Neoplasms 2Squamous Non-small Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solid Malignancies 1Neoplasms 1Lung Cancer Metastatic 1Colorectal Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced Rare Tumours 1

Interventions

Fluorouracil 29Leucovorin 26Oxaliplatin 25Capecitabine 16Irinotecan 14Cetuximab 10Bevacizumab 9Radiotherapy 8Panitumumab 5Folfox protocol 5Surgical Procedures, Operative 3Levamisole 3Celecoxib 3tremelimumab 2neratinib 2napabucasin 2durvalumab 2cediranib 2aflibercept 2X-Rays 2Tegafur 2Radiofrequency Ablation 2Psychiatric Rehabilitation 2Preoperative Exercise 2Octreotide 2Mitomycin 2Interviews as Topic 2Immunoglobulin G 2Folic Acid 2Floxuridine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Colorectal Neoplasms × tremelimumab × Clear all
NCT02870920 2023-12-08

Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

Canadian Cancer Trials Group

Phase 2 Completed
180 enrolled 13 charts
Gastrointestinal

Colorectal Neoplasms

NCT03101475 2022-05-31

ILOC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
22 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡